相关实验视频

Updated: Jul 6, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

下一代测序对晚期非小细胞肺癌患者的有效性:基于人口的注册研究

D-W Kang1, S-K Park2, Y L Yu3

  • 1School of Pharmacy, Sungkyunkwan University, Suwon.

ESMO open
|January 9, 2024
PubMed
概括

下一代测序 (NGS) 没有改善晚期非小细胞肺癌 (NSCLC) 患者的生存率. 当资源有限时,单基因测试 (SGT) 跟着NGS可能更有效.

关键词:
远端转移的发生.这是下一代测序.其他非小细胞肺癌.现实世界的证据.单基因测试是一种单基因测试.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

相关概念视频

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.9K